Skip to content
Governance Register

← US public companies

Cullinan Therapeutics, Inc.

SEC CIK 1789972 · CGEM · last insider filing 2026-06-18

Directors (from insider filings)

NameCapacity as filedFilings
Thistle Mary Director filed 2024–2026
Allen Andrew R Director filed 2025–2026
Webster Stephen W Director filed 2021–2026
Rosenberg Anthony Director filed 2021–2026
Meek David D. Director filed 2024–2026
Doyle Mittie Director filed 2025–2026
Ahmed Nadim Director · President and CEO filed 2021–2026
Martin Anne-Marie Director filed 2022–2025
Ryan David P. Director filed 2022–2025
Ebeling Thomas Director filed 2021–2024
Gadicke Ansbert Director filed 2021–2023
Jovan-Embiricos Morana Director filed 2021–2022
Hughes Owen Director · President and CEO filed 2021–2021

Officers (from insider filings)

NameTitle as filedFilings
Michaelson Jennifer See Remarks filed 2021–2026
Sumer Jacquelyn L Chief Legal Officer filed 2022–2026
Jones Jeffrey Alan Chief Medical Officer filed 2022–2026
Fenton Mary Kay Chief Financial Officer filed 2024–2026
Savill Corrine Chief Business Officer filed 2021–2026
Nguyen Nate Interim PAO and PFO filed 2024–2024
Trigilio Jeffrey Chief Financial Officer filed 2021–2024
Baeuerle Patrick See Remarks filed 2021–2023
Keane Raymond T Chief Legal Officer filed 2021–2022
Zawel Leigh See Remarks filed 2021–2022
Wigginton Jon Marc Chief Medical Officer filed 2021–2021

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.